Skip to Main Content

Paper Details

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
1
2023
Author NameAffiliation
Paul HambergFranciscus Gasthuis & Vlietland Hospital Rotterdam and Schiedam
Martijn P LolkemaErasmus MC Cancer Institute, Erasmus University Medical Center
Ronald de WitErasmus MC Cancer Institute, Erasmus University Medical Center
  • 1 - 3

Datasets

Release 1.2